Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-040670
Filing Date
2025-08-18
Accepted
2025-08-18 16:33:31
Documents
1
Period of Report
2025-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1755549206.html 4  
1 FORM 4 wk-form4_1755549206.xml 4 3571
  Complete submission text file 0001628280-25-040670.txt   5012
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EMERGENT BIOSOLUTIONS INC. 300 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address
Zoon Kathryn C (Reporting) CIK: 0001685720 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 251228345